BCT — Bluechiip Share Price
0.000.00%
Last trade - 00:00- AU$9.54m
- AU$9.74m
- AU$0.92m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 8.06 | ||
| Price to Tang. Book | 8.06 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 13.25 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -444.17% | ||
| Return on Equity | -320.73% | ||
| Operating Margin | -801.51% | ||
Financial Summary
| Year End 30th Jun | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 1.03 | 0.24 | 0.05 | 0.93 | 0.92 | n/a | n/a | 10.26% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Bluechiip Limited is an Australia-based company, which is engaged in the development of advanced sample management solutions for harsh environments. The principal activity of the Company is the development and commercialization of a wireless tracking solution for the healthcare and life science, security, defense, and manufacturing industries. Its solutions include Bluechiip Enabled Solutions, Custom Solutions and Partnerships. The Company offers a range of services across product design, engineering and manufacturing. It also offers partners the ability to license its patented technology to differentiate their product and service offerings. The Company’s Sample Storage solutions include Bluechiip Enabled CryoVial Range, Bluechiip Enabled CryoBoxes, Bluechiip Enabled CryoTags and a range of accessories for all advanced sample management needs. Its Readers solutions include Bluechiip Enabled Handheld Reader, Bluechiip Enabled Multivial Reader and Bluechiip Enabled CryoBox Tracker.
Directors
- Iain Macgregor Kirkwood NEC
- Andrew McLellan MDR
- Lee Mitchell SEC
- Chelsea Sheridan SEC
- Andrew Cox NID
- Michael Ohanessian NID
- Last Annual
- June 30th, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- May 20th, 2003
- Public Since
- June 9th, 2011
- No. of Employees
- 7
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 1,363,497,933
- Address
- 1 Dalmore Drive scoresby, MELBOURNE, 3179
- Web
- https://www.bluechiip.com/
- Phone
- +61 397639763
- Auditors
- Deloitte Touche Tohmatsu
Upcoming Events for BCT
Similar to BCT
4DMedical
Australian Stock Exchange - SEATS
Adherium
Australian Stock Exchange - SEATS
Allegra Medical Technologies
Australian Stock Exchange - SEATS
Ansell
Australian Stock Exchange - SEATS
Anteris Technologies
Australian Stock Exchange - SEATS
FAQ
What is the Bluechiip share price?
As of Today at 19:04 UTC, shares in Bluechiip are trading at AU$0.01. This share price information is delayed by 15 minutes.
How has the Bluechiip share price performed this year?
Shares in Bluechiip last closed at AU$0.01 and the price had moved by -73.08% over the past 365 days. In terms of relative price strength the Bluechiip share price has underperformed the ASX All Ordinaries Index by -74.92% over the past year.
What are the analyst and broker recommendations for Bluechiip?
There is no consensus recommendation for this security.
What is the Bluechiip dividend yield?
Bluechiip does not currently pay a dividend.
Does Bluechiip pay a dividend?
Bluechiip does not currently pay a dividend.
When does Bluechiip next pay dividends?
Bluechiip does not currently pay a dividend.
How do I buy Bluechiip shares?
To buy shares in Bluechiip you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Bluechiip?
As of the previous close price of AU$0.01, shares in Bluechiip had a market capitalisation of AU$9.54m.
Where are Bluechiip shares listed?
Here are the trading details for Bluechiip:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: BCT
What kind of share is Bluechiip?
Based on an overall assessment of its quality, value and momentum Bluechiip is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Bluechiip share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Bluechiip share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bluechiip. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -76.83%.
As of the last closing price of AU$0.01, shares in Bluechiip were trading -62.16% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Bluechiip PE Ratio?
The Bluechiip PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Bluechiip?
Bluechiip's management team is headed by:
- Iain Macgregor Kirkwood - NEC
- Andrew McLellan - MDR
- Lee Mitchell - SEC
- Chelsea Sheridan - SEC
- Andrew Cox - NID
- Michael Ohanessian - NID